Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Healthequity (HQY) over the last 13 years, with Q4 2025 value amounting to $138.6 million.

  • Healthequity's Cash from Operations rose 5303.7% to $138.6 million in Q4 2025 from the same period last year, while for Oct 2025 it was $414.9 million, marking a year-over-year increase of 2161.49%. This contributed to the annual value of $339.9 million for FY2025, which is 3995.87% up from last year.
  • According to the latest figures from Q4 2025, Healthequity's Cash from Operations is $138.6 million, which was up 5303.7% from $135.9 million recorded in Q3 2025.
  • Healthequity's 5-year Cash from Operations high stood at $138.6 million for Q4 2025, and its period low was $7.1 million during Q2 2022.
  • Over the past 5 years, Healthequity's median Cash from Operations value was $59.0 million (recorded in 2021), while the average stood at $63.7 million.
  • Its Cash from Operations has fluctuated over the past 5 years, first plummeted by 7711.04% in 2022, then soared by 34564.08% in 2023.
  • Healthequity's Cash from Operations (Quarter) stood at $22.3 million in 2021, then soared by 115.22% to $47.9 million in 2022, then increased by 19.14% to $57.1 million in 2023, then skyrocketed by 58.56% to $90.6 million in 2024, then skyrocketed by 53.04% to $138.6 million in 2025.
  • Its last three reported values are $138.6 million in Q4 2025, $135.9 million for Q3 2025, and $64.7 million during Q2 2025.